Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface complex N-glycan-bearing receptors and adhesion molecules represent a functional class of glycoproteins, including EGFR, TGF-beta receptors, and integrins, that are modified with beta-1,6-branched N-glycans by the enzyme MGAT5 (Dennis et al., 2009, Cell). These glycans act as ligands for galectins, particularly Galectin-3, which cross-links them to form a dynamic "galectin-glycan lattice" on the cell surface (Lau et al., 2007, Cell). This lattice is a critical regulator of cell signaling, as it prevents the constitutive endocytosis of the receptors, thereby maintaining their presence and activity at the plasma membrane. In diseases such as cancer and fibrosis, the lattice is often reinforced, leading to aberrant signaling that promotes tumor progression, metastasis, and tissue scarring (Partridge et al., 2004, Science). Therapeutic intervention typically involves small molecules or carbohydrate-based inhibitors that target the galectin's carbohydrate-recognition domain, thereby disrupting the lattice and allowing for the internalization and degradation of the associated receptors (Blanchard et al., 2014, Chem Biol).
Inhibition of galectin binding to the carbohydrate-recognition domain of complex N-glycan-bearing receptors, which disrupts the galectin-glycan lattice and promotes receptor internalization and degradation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface complex N-glycan-bearing receptors and adhesion molecules.